APA (7th ed.) Citation

Amit A. Joharapurkar, Vishal J. Patel, Samadhan G. Kshirsagar, Maulik S. Patel, Hardikkumar H. Savsani, Chetan Kajavadara, . . . Mukul R. Jain. (2022). Prolyl hydroxylase inhibitor desidustat improves anemia in erythropoietin hyporesponsive state. Elsevier.

Chicago Style (17th ed.) Citation

Amit A. Joharapurkar, Vishal J. Patel, Samadhan G. Kshirsagar, Maulik S. Patel, Hardikkumar H. Savsani, Chetan Kajavadara, Darshan Valani, and Mukul R. Jain. Prolyl Hydroxylase Inhibitor Desidustat Improves Anemia in Erythropoietin Hyporesponsive State. Elsevier, 2022.

MLA (9th ed.) Citation

Amit A. Joharapurkar, et al. Prolyl Hydroxylase Inhibitor Desidustat Improves Anemia in Erythropoietin Hyporesponsive State. Elsevier, 2022.